OmniAb raises 2026 cash guidance on licensing activity

Go back to OmniAb raises 2026 cash guidance on licensing activity

OmniAb Raises 2026 Financial Guidance

August 17, 2026 6:06 AM EDT

Increases Full Year 2026 Cash Outlook Following Recent Technology Licensing Activity

EMERYVILLE, Calif.--(BUSINESS WIRE)-- OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today raised its 2026 cash and cash equivalents financial guidance following recent technology licensing activity.

Recent business development and licensing activity has enabled us to again raise our 2026 financial guidance and significantly increase our cash outlook, stated Matt Foehr, Chief Executive Officer of OmniAb. Our business at OmniAb continues to strengthen as the reach... More